2014, Number 610
<< Back Next >>
Rev Med Cos Cen 2014; 71 (610)
El glaucoma y su tratamiento farmacológico
Laporte QG
Language: Spanish
References: 13
Page: 297-303
PDF size: 300.74 Kb.
ABSTRACT
Glaucoma is an ophthalmologic
pathology, very important to
public health. According to the
World Health Organization
WHO, 8 million people are
blind because of glaucoma,
being the third cause of
blindness worldwide. Glaucoma
principally affects adults older
than 40 years, it's prevalence
increase greatly with age and is
getting higher with the longer
life expectative. The intraocular
pressure it’s the main risk
factor, although there are cases
of normal-pressure glaucoma.
The first line therapy consist in
lower the IOP, using daily eye
drop medications, regulating
the intraocular balance. This
article pretends to learn
more about glaucoma, its
consequences and the available
pharmacologic therapy now
days.
REFERENCES
American Academy of Ophthalmology. Glaucoma. Basic and Clinical Science Course. 2011- 2012
Dietlein TS, Hermann MM, Jordan JF. The Medical and surgical Treatment of Glaucoma. Deutsches Arzteblatt Internacional. Dtsch Arztebl Int 2009;106(37):597-605
Hodapp E, Parrish RK, Richard K, Anderson DR. Follow-up of primary open-angle glaucoma. Clinical decision in glaucoma. St. Louis: Mosby; 1993. p. 84-126
Kanski, JJ, Bowling B. Oftalmología Clínica. 7a ed. Elsevier. Barcelona, España, 2012.
Lieberman MF, Congdon NG, He M. The value of test in the diagnosis and management of glaucoma. Elsevier. Am J Opthalmology 2011;152:889- 899
Martín P Y et al. Fisiología Trabecular y glaucoma de ángulo abierto. Revista cubana de oftalmología. Vol 25, No 3. 2012
Mozaffarieh M, Flammer J. New insights in the pathogenesis and treatment of normal tension glaucoma. Elsevier. Current opinion in pharmacology, 2013, 13:43-49
Paz-Moreno J. Arranz Márquez E. Teus Guezala M.A. GLAUCOMA. Actualización. Medicine. 2011;10(91):6158-66
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3):262-7
Quigley HA. Wilmer. GLAUCOMA. Lancet 2011;377:1367-77
Tressler CS, Beatty R, Lemp MA. Preservative use in topical glaucoma medications. 2011;9(3):140-158
Vohra R. et al, BSc Medicine. The role of inflammation in the pathogenesis of glaucoma. Elsevier. Survey of ophthalmology. Vol 58.No 4. 2013
www.elsevier.es/kanski_oftalmologiaclinica/galeriaimagenes/glaucoma/cambiosepecificos.
Full text